CLABSI Candidate
Back to DashboardPatient Information
- Patient Name
- Emma Miller
- MRN
- NHSN726370
- Location
- -
Culture Information
- Organism
- Escherichia coli
- Collected
- 01/17/2026 23:21
- Source
- Blood
CLABSI Details
Device Days
11
Line Site
Right basilic vein
Line Type
Picc
Inserted
01/06/2026
Removed
-
LLM Classifications
Not HAI
80.0% confidence
2026-01-18 13:37
Reasoning:
Case meets basic CLABSI eligibility criteria MBI-LCBI: Escherichia coli IS an MBI-eligible organism MBI-LCBI: Patient meets population criteria - Neutropenia documented in notes (ANC value not extracted) MBI-LCBI: Mucosal barrier injury documented - mucositis (grade 2) CLASSIFICATION: MBI-LCBI - Organism (Escherichia coli) is intestinal/oral flora - Patient meets population criteria (Neutropenia documented in notes (ANC value not extracted)) - Mucosal barrier injury documented (mucositis (grade 2)) Per NHSN, this is MBI-LCBI, not CLABSI Review flags: - Verify ANC value for MBI-LCBI neutropenia criterion - MBI-LCBI classification requires IP verification
Alternative Source: MBI-LCBI (mucosal barrier injury)
Supporting Evidence:
Progress Note: 2026-01-18: Michael Chen, MD
Line infection suspected by clinical team
Supports CLABSI attribution
Progress Note: 2026-01-18: Michael Chen, MD
Mucositis documented (Grade 2)
MBI-LCBI: Mucosal barrier injury factor
Progress Note: 2026-01-18: Michael Chen, MD
Neutropenia documented
MBI-LCBI: Immunocompromised status
Progress Note: 2026-01-18: Michael Chen, MD
Stem cell transplant (allogeneic)
MBI-LCBI: Transplant status
Contradicting Evidence:
Progress Note: 2026-01-18: Michael Chen, MD
Central line in place but organism consistent with gut translocation.
Possible alternate source: gut
NHSN Criteria Assessment
Initial Screening Criteria
BSI with central line present >2 days
LLM Classification
LLM review complete
IP Review
Confirmed not HAI